1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Olanzapine |
| brand | String | Zyprexa (oral, IM acute), Zyprexa Zydis (ODT), Zyprexa Relprevv (LAI), Lybalvi (with samidorphan) |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Neuroleptics|Neuroleptic]] • [[:Category:Atypical neuroleptics|Atypical neuroleptic (second-generation)]] • [[:Category:Thienobenzodiazepines|Thienobenzodiazepine]] • [[:Category:Mood stabilizers|Mood stabilizer]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-0000001F-QINU`"', '"`UNIQ--vote-00000020-QINU`"', '"`UNIQ--vote-00000021-QINU`"', '"`UNIQ--vote-00000022-QINU`"', '"`UNIQ--vote-00000023-QINU`"', '"`UNIQ--vote-00000024-QINU`"', '"`UNIQ--vote-00000025-QINU`"' |
| starting_dose | String | Schizophrenia / acute mania: 5-10 mg PO once daily, target 10-15 mg/day. Acute agitation IM: 10 mg, may repeat in 2 hours. Relprevv LAI: 150-300 mg every 4 weeks after oral overlap |
| preparations | String | Tablets 2.5, 5, 7.5, 10, 15, 20 mg; ODT (Zydis) 5, 10, 15, 20 mg; acute IM injection 10 mg/vial; Relprevv LAI 210, 300, 405 mg vials |
| fda_max | String | 20 mg/day (oral) |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral • intramuscular (acute and long-acting) |
| onset | String | Sedation from first dose; neuroleptic effect emerges over days to weeks |
| duration | String | 24 hours (oral); 2-4 weeks (LAI) |
| halflife | String | 21-54 hours'"`UNIQ--ref-00000026-QINU`"' |
| bioavailability | String | ~60% (oral); ~100% (IM)'"`UNIQ--ref-00000027-QINU`"' |
| pregnancy | String | Signal for gestational diabetes and metabolic syndrome with maternal exposure; the metabolic load can be substantial during pregnancy.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | |
